FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4376133623> ?p ?o ?g. }

• W4376133623 abstract "Abstract Sitravatinib is an immunomodulatory tyrosine kinase inhibitor that can augment responses when combined with programmed death-1 inhibitors such as nivolumab. We report a single-arm, interventional, phase 2 study of neoadjuvant sitravatinib in combination with nivolumab in patients with locally advanced clear cell renal cell carcinoma (ccRCC) prior to curative nephrectomy (NCT03680521). The primary endpoint was objective response rate (ORR) prior to surgery with a null hypothesis ORR = 5% and the alternative hypothesis set at ORR = 30%. Secondary endpoints were safety; pharmacokinetics (PK) of sitravatinib; immune effects, including changes in programmed cell death–ligand 1 expression; time-to-surgery; and disease-free survival (DFS). Twenty patients were evaluable for safety and 17 for efficacy. The ORR was 11.8%, and 24-month DFS probability was 88·0% (95% CI 61.0 to 97.0). There were no grade 4/5 treatment-related adverse events. Sitravatinib PK did not change following the addition of nivolumab. Correlative blood and tissue analyses showed changes in the tumour microenvironment resulting in an immunologically active tumour by the time of surgery (median time-to-surgery: 50 days). The primary endpoint of this study was not met as short-term neoadjuvant sitravatinib and nivolumab did not substantially increase ORR." @default.
• W4376133623 created "2023-05-12" @default.
• W4376133623 creator A5004276467 @default.
• W4376133623 creator A5008861348 @default.
• W4376133623 creator A5011615408 @default.
• W4376133623 creator A5016967734 @default.
• W4376133623 creator A5017490262 @default.
• W4376133623 creator A5017537551 @default.
• W4376133623 creator A5022003021 @default.
• W4376133623 creator A5023697606 @default.
• W4376133623 creator A5028085268 @default.
• W4376133623 creator A5042506301 @default.
• W4376133623 creator A5042557251 @default.
• W4376133623 creator A5043477787 @default.
• W4376133623 creator A5050132330 @default.
• W4376133623 creator A5058115259 @default.
• W4376133623 creator A5059197047 @default.
• W4376133623 creator A5059272502 @default.
• W4376133623 creator A5061555567 @default.
• W4376133623 creator A5073556374 @default.
• W4376133623 creator A5080220488 @default.
• W4376133623 creator A5086388587 @default.
• W4376133623 creator A5090338744 @default.
• W4376133623 creator A5091361798 @default.
• W4376133623 date "2023-05-10" @default.
• W4376133623 modified "2023-10-14" @default.
• W4376133623 title "Phase II trial of neoadjuvant sitravatinib plus nivolumab in patients undergoing nephrectomy for locally advanced clear cell renal cell carcinoma" @default.
• W4376133623 cites W1506448700 @default.
• W4376133623 cites W1994581907 @default.
• W4376133623 cites W2011073666 @default.
• W4376133623 cites W2101670384 @default.
• W4376133623 cites W2113073012 @default.
• W4376133623 cites W2123106337 @default.
• W4376133623 cites W2130410032 @default.
• W4376133623 cites W2144173184 @default.
• W4376133623 cites W2308610579 @default.
• W4376133623 cites W2414641360 @default.
• W4376133623 cites W2415766229 @default.
• W4376133623 cites W2522313999 @default.
• W4376133623 cites W2559382297 @default.
• W4376133623 cites W2620473448 @default.
• W4376133623 cites W2737082469 @default.
• W4376133623 cites W2890360625 @default.
• W4376133623 cites W2898915459 @default.
• W4376133623 cites W2929039582 @default.
• W4376133623 cites W2971975780 @default.
• W4376133623 cites W3002780060 @default.
• W4376133623 cites W3130143514 @default.
• W4376133623 cites W3134137756 @default.
• W4376133623 cites W3135213711 @default.
• W4376133623 cites W3196207248 @default.
• W4376133623 cites W3202999930 @default.
• W4376133623 cites W4212764943 @default.
• W4376133623 cites W4224224667 @default.
• W4376133623 cites W4229029457 @default.
• W4376133623 cites W4234863521 @default.
• W4376133623 cites W4282945389 @default.
• W4376133623 cites W4285719527 @default.
• W4376133623 doi "https://doi.org/10.1038/s41467-023-38342-7" @default.
• W4376133623 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37164948" @default.
• W4376133623 hasPublicationYear "2023" @default.
• W4376133623 type Work @default.
• W4376133623 citedByCount "2" @default.
• W4376133623 countsByYear W43761336232022 @default.
• W4376133623 countsByYear W43761336232023 @default.
• W4376133623 crossrefType "journal-article" @default.
• W4376133623 hasAuthorship W4376133623A5004276467 @default.
• W4376133623 hasAuthorship W4376133623A5008861348 @default.
• W4376133623 hasAuthorship W4376133623A5011615408 @default.
• W4376133623 hasAuthorship W4376133623A5016967734 @default.
• W4376133623 hasAuthorship W4376133623A5017490262 @default.
• W4376133623 hasAuthorship W4376133623A5017537551 @default.
• W4376133623 hasAuthorship W4376133623A5022003021 @default.
• W4376133623 hasAuthorship W4376133623A5023697606 @default.
• W4376133623 hasAuthorship W4376133623A5028085268 @default.
• W4376133623 hasAuthorship W4376133623A5042506301 @default.
• W4376133623 hasAuthorship W4376133623A5042557251 @default.
• W4376133623 hasAuthorship W4376133623A5043477787 @default.
• W4376133623 hasAuthorship W4376133623A5050132330 @default.
• W4376133623 hasAuthorship W4376133623A5058115259 @default.
• W4376133623 hasAuthorship W4376133623A5059197047 @default.
• W4376133623 hasAuthorship W4376133623A5059272502 @default.
• W4376133623 hasAuthorship W4376133623A5061555567 @default.
• W4376133623 hasAuthorship W4376133623A5073556374 @default.
• W4376133623 hasAuthorship W4376133623A5080220488 @default.
• W4376133623 hasAuthorship W4376133623A5086388587 @default.
• W4376133623 hasAuthorship W4376133623A5090338744 @default.
• W4376133623 hasAuthorship W4376133623A5091361798 @default.
• W4376133623 hasBestOaLocation W43761336231 @default.
• W4376133623 hasConcept C121608353 @default.
• W4376133623 hasConcept C126322002 @default.
• W4376133623 hasConcept C126894567 @default.
• W4376133623 hasConcept C143998085 @default.
• W4376133623 hasConcept C197934379 @default.
• W4376133623 hasConcept C203092338 @default.
• W4376133623 hasConcept C2777472916 @default.
• W4376133623 hasConcept C2777546739 @default.
• W4376133623 hasConcept C2777701055 @default.
• W4376133623 hasConcept C2778292576 @default.
• W4376133623 hasConcept C2780030458 @default.

• next